Cleared Traditional

SC HONKYTONK PTCA Balloon Dilatation Catheter (K223022) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
139d
Days
Class 2
Risk

K223022 is an FDA 510(k) clearance for the SC HONKYTONK PTCA Balloon Dilatation Catheter. Classified as Catheters, Transluminal Coronary Angioplasty, Percutaneous (product code LOX), Class II - Special Controls.

Submitted by Sino Medical Sciences Technology, Inc. (Tianjin, CN). The FDA issued a Cleared decision on February 15, 2023 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5100 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Sino Medical Sciences Technology, Inc. devices

Submission Details

510(k) Number K223022 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2022
Decision Date February 15, 2023
Days to Decision 139 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 125d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5100
Definition A Ptca Catheter Is A Device That Operates On The Principle Of Hydraulic Pressurization Applied Through An Inflatable Balloon Attached To The Distal End.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

CardioMed Device Consultants, LLC
Semih Oktay

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous

All 43
Devices cleared under the same product code (LOX) and FDA review panel - the closest regulatory comparables to K223022.
Firefighter™ NC Pro PTCA Balloon Catheter
K223189 · Shanghai MicroPort Medical (Group) Co., Ltd. · Jul 2023
Coronary Dilatation Balloon Catheter (VesPenetrator®), Coronary Dilatation Balloon Catheter (VesTraveler®), Coronary Dilatation Balloon Catheter (VexPander®)
K230374 · Dongguan TT Medical, Inc. · Jun 2023
POT PTCA Balloon Dilatation Catheter
K230705 · Brosmed Medical Co., Ltd. · Apr 2023
NC ROCKSTAR Non-Compliant PTCA Balloon Dilatation Catheter
K222538 · Sino Medical Sciences Technology, Inc. · Dec 2022
NC TREK NEO Coronary Dilatation Catheter
K220634 · Abbott Vascular · Jun 2022
Emerge Monorail PTCA Dilatation Catheter
K220629 · Boston Scientific · Mar 2022